Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease.

[1]  R. Vessella,et al.  DIAPH3 governs the cellular transition to the amoeboid tumour phenotype , 2012, EMBO molecular medicine.

[2]  J. Bono,et al.  The changing therapeutic landscape of castration-resistant prostate cancer , 2011, Nature Reviews Clinical Oncology.

[3]  G. Camussi,et al.  Tumor exploits alternative strategies to achieve vascularization , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  Ryoji Kato,et al.  Expected clinical applications of circulating tumor cells in breast cancer. , 2011, World journal of clinical oncology.

[5]  N. Beauchemin.  The Colorectal Tumor Microenvironment: The Next Decade , 2011, Cancer Microenvironment.

[6]  Guido Jenster,et al.  Exosomes as biomarker treasure chests for prostate cancer. , 2011, European urology.

[7]  P. Kuo,et al.  Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. , 2011, Carcinogenesis.

[8]  Ann Pellegrini.  Movement , 2011 .

[9]  E. Germain,et al.  Brain-Derived Neurotrophic Factor and Neurotrophin-4/5 Are Expressed in Breast Cancer and Can Be Targeted to Inhibit Tumor Cell Survival , 2011, Clinical Cancer Research.

[10]  J. Rak,et al.  Microvesicles as mediators of intercellular communication in cancer—the emerging science of cellular ‘debris’ , 2011, Seminars in Immunopathology.

[11]  C. Turner,et al.  Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis , 2011, Molecular biology of the cell.

[12]  Francesco Favero,et al.  Reduced Expression of the ROCK Inhibitor Rnd3 Is Associated with Increased Invasiveness and Metastatic Potential in Mesenchymal Tumor Cells , 2010, PloS one.

[13]  Nancy Guillen,et al.  Dynamic instability of the intracellular pressure drives bleb-based motility , 2010, Journal of Cell Science.

[14]  R. Adam,et al.  An Akt- and Fra-1-dependent pathway mediates platelet-derived growth factor-induced expression of thrombomodulin, a novel regulator of smooth muscle cell migration. , 2010, The American journal of pathology.

[15]  Gerhard Christofori,et al.  Mechanisms of Motility in Metastasizing Cells , 2010, Molecular Cancer Research.

[16]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[17]  M. Rubin,et al.  ERG rearrangement metastasis patterns in locally advanced prostate cancer. , 2010, Urology.

[18]  Graca Raposo,et al.  ARF6-Regulated Shedding of Tumor Cell-Derived Plasma Membrane Microvesicles , 2009, Current Biology.

[19]  R. Premont,et al.  Metastasis: Wherefore Arf Thou? , 2009, Current Biology.

[20]  F. Sotgia,et al.  An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease spread and epithelial Akt activation , 2009, Cell cycle.

[21]  M. Rubin,et al.  Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. , 2009, Cancer research.

[22]  J. Rak,et al.  Microvesicles: Messengers and mediators of tumor progression , 2009, Cell cycle.

[23]  A. Toker,et al.  Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. , 2009, Cellular signalling.

[24]  M. Rubin,et al.  Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation. , 2009, Cancer research.

[25]  J. Krijgsveld,et al.  Exosomal Secretion of Cytoplasmic Prostate Cancer Xenograft-derived Proteins* , 2009, Molecular & Cellular Proteomics.

[26]  Jacopo Meldolesi,et al.  Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.

[27]  E. Sahai,et al.  Rac Activation and Inactivation Control Plasticity of Tumor Cell Movement , 2008, Cell.

[28]  M. Klagsbrun,et al.  Calcification of multipotent prostate tumor endothelium. , 2008, Cancer cell.

[29]  A. Guha,et al.  Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.

[30]  M. Loda,et al.  Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase , 2008, Cell cycle.

[31]  A. Luini,et al.  Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation , 2008, Journal of Cell Science.

[32]  Thomas Walz,et al.  Negative Staining and Image Classification – Powerful Tools in Modern Electron Microscopy , 2004, Biological Procedures Online.

[33]  T. Manabe,et al.  GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion , 2008, Nature Cell Biology.

[34]  Gerhard Christofori,et al.  Distinct mechanisms of tumor invasion and metastasis. , 2007, Trends in molecular medicine.

[35]  P. Yelick,et al.  The pro‐apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1 , 2007, The EMBO journal.

[36]  Adam S. Kibel,et al.  Integrative molecular concept modeling of prostate cancer progression , 2007 .

[37]  M. Loda,et al.  Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression , 2007, Cancer biology & therapy.

[38]  Pierre Roux,et al.  Loss of p53 promotes RhoA–ROCK-dependent cell migration and invasion in 3D matrices , 2007, The Journal of cell biology.

[39]  Jayoung Kim,et al.  Cholesterol sensitivity of endogenous and myristoylated Akt. , 2007, Cancer research.

[40]  T. Ratliff.  Caveolin-1 Promotes Tumor Progression in an Autochthonous Mouse Model of Prostate Cancer: Genetic Ablation of Cav-1 Delays Advanced Prostate Tumor Development in Tramp Mice , 2006 .

[41]  Jason A. Koutcher,et al.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.

[42]  M. Loda,et al.  Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. , 2005, The Journal of biological chemistry.

[43]  M. Becich,et al.  Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  R. Tibshirani,et al.  Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[45]  A. Sonnenberg,et al.  Stimulation‐Dependent Recycling of Integrin β1 Regulated by ARF6 and Rab11 , 2004, Traffic.

[46]  E. Latulippe,et al.  Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. , 2004, The American journal of pathology.

[47]  P. Nelson,et al.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.

[48]  E. Lander,et al.  Gene expression correlates of clinical prostate cancer behavior. , 2002, Cancer cell.

[49]  J F Leary,et al.  Doublet discrimination in DNA cell-cycle analysis. , 2001, Cytometry.

[50]  M. Ittmann,et al.  Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. , 2001, Cancer research.

[51]  G. Thurston,et al.  Mechanics of endothelial cell architecture and vascular permeability. , 2001, Critical reviews in biomedical engineering.

[52]  P. Eggli,et al.  Protrusive activity, cytoplasmic compartmentalization, and restriction rings in locomoting blebbing Walker carcinosarcoma cells are related to detachment of cortical actin from the plasma membrane. , 1998, Cell motility and the cytoskeleton.

[53]  M A Moses,et al.  Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). , 1994, The Journal of biological chemistry.